Essential Steps to Set Java Path Like a Pro Setting the Java path is a crucial step for anyone working with Java development, whether you’re a novice programmer or an experienced developer. If you’re ...

Actor David Hasselhoff was spotted utilizing a walker during a public outing, an appearance representatives clarified is due to the actor recovering from knee and hip replacement surgeries. The ...

Many people are turning to artificial intelligence for personal finance advice. Writing a good AI prompt can mean the difference between receiving a reasonable or poor output, experts said. While AI ...

EDMONDS, Wash. — Syreh Sonko is studying nursing at Edmonds College through Washington state's Running Start, but the program that's saving her nearly $30,000 in college costs may soon look different.

President Trump said there would likely be more American casualties as the U.S. military continues strikes against Iran. Photo: The White House Now that is being put to the test, as the U.S. races to ...

State lawmakers might reduce funding for Running Start, a program that lets high school juniors and seniors take courses and earn credits at community and technical colleges. Running Start students ...

AI expert Allie K. Miller demonstrates Anthropic's Claude Cowork, an AI agent tool that automates extensive business tasks. It analyzes documents, conducts research, builds interactive dashboards, and ...

I can't stand opening the Microsoft Store. It's slow to load, confusing to browse, and full of ads for things I don't care about. Luckily, thanks to a new feature, I don't have to open the Microsoft ...

The ruling by the Oregon Land Use Board of Appeals favors the city’s plans to build a plant to filter water from the forested watershed. A demonstration of operations at a pilot water treatment plant, ...

Texas’ medical marijuana program is expanding, with new laws now in effect that increase access for patients across the state, including in North Texas. While much of the debate in 2025 centered on ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.